WC
SFE

Wexford Capital’s Safeguard Scientifics, Inc. SFE Stock Holding History

Wexford Capital’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,725
Closed -$43K – 378
2020
Q4 		$43K Buy
+6,725
New +$42K 0.01% 207

Other funds holding SFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Wexford Capital's SFE Position: Q1 2021 in Review

Wexford Capital sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2021, closing a stake of 6,725 shares — an estimated $43K sold.

Wexford Capital first reported a position in SFE in Q4 2020 and held it in 1 quarter. The position peaked at $43K in Q4 2020. 84 funds tracked by Wall St. Rank hold SFE as of Q1 2021.

  • Wexford Capital reported no remaining Safeguard Scientifics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Wexford Capital sold 6,725 Safeguard Scientifics, Inc. shares in Q1 2021, an estimated $43K.
  • Wexford Capital first reported a position in Safeguard Scientifics, Inc. in Q4 2020 and held it in 1 quarter.
  • Wexford Capital's Safeguard Scientifics, Inc. position peaked at $43K in Q4 2020.
  • 84 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.